Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Diabetes Mellitus × sofosbuvir-velpatasvir drug combination × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C 2 Carcinoma, Hepatocellular 2 Recurrence 1 Hepatitis C, Chronic 1 Fibrosis 1 Diabetes Mellitus 1 Cardiovascular Diseases 1

Interventions

sofosbuvir-velpatasvir drug combination 1 amlodipine, atorvastatin drug combination 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03520660 2026-03-11

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institutes of Health Clinical Center (CC)

Phase 4 Active not recruiting

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡